Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis

The Lancet Global Health

Volumn 2, Issue 2, 2014, Pages

  Wong, Wan Ling ^a,b   Su, Xinyi ^a,b   Li, Xiang ^a,c   Cheung, Chui Ming G ^a   Klein, Ronald ^d   Cheng, Ching Yu ^a,b,e,f   Wong, Tien Yin ^a,b  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^f DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; BAYES THEOREM; COST OF ILLNESS; ETHNOLOGY; FEMALE; FORECASTING; HEALTH; HEALTH SURVEY; HUMAN; MACULAR DEGENERATION; MALE; META ANALYSIS; MIDDLE AGED; PREVALENCE; SEX DIFFERENCE; STATISTICAL MODEL; TRENDS; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BAYES THEOREM; COST OF ILLNESS; FEMALE; FORECASTING; GLOBAL HEALTH; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; MODELS, STATISTICAL; POPULATION SURVEILLANCE; PREVALENCE; SEX FACTORS;

EID: 84892965801     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(13)70145-1     Document Type: Article

References (51)

1. Klein R, Klein BE, Cruickshanks KJ The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 1999, 18:371-389.
2. Mitchell P, Smith W, Attebo K, Wang JJ Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995, 102:1450-1460.
3. Klaver CC, Assink JJ, van Leeuwen R, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 2001, 42:2237-2241.
4. Kawasaki R, Yasuda M, Song SJ, et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 2010, 117:921-927.
5. Wong TY, Chakravarthy U, Klein R, et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 2008, 115:116-126.
6. Lim LS, Mitchell P, Seddon JM, et al. Age-related macular degeneration. Lancet 2012, 379:1728-1738.
7. Bressler NM Age-related macular degeneration is the leading cause of blindness. JAMA 2004, 291:1900-1901.
8. Bressler NM, Doan QV, Varma R, et al. Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. Arch Ophthalmol 2011, 129:709-717.
9. Gemmy Cheung CM, Li X, Cheng C-Y, et al. Prevalence and risk factors for age-related macular degeneration in Indians: a comparative study in Singapore and India. Am J Ophthalmol 2013, 155:764. 73.e3.
10. Wong TY, Liew G, Mitchell P Clinical update: new treatments for age-related macular degeneration. Lancet 2007, 370:204-206.
11. Martin DF, Maguire MG, Ying GS, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011, 364:1897-1908.
12. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006, 355:1419-1431.
13. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006, 355:1432-1444.
14. Klein BE, Klein R Forecasting age-related macular degeneration through 2050. JAMA 2009, 301:2152-2153.
15. Klein R, Klein BE, Knudtson MD, et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 2006, 113:373-380.
16. Klein R, Chou CF, Klein BE, et al. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 2011, 129:75-80.
17. Rudnicka AR, Jarrar Z, Wormald R, et al. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 2012, 119:571-580.
18. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000, 283:2008-2012. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
19. de Weerd M, Greving JP, de Jong AW, et al. Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis. Stroke 2009, 40:1105-1113.
20. Augood CA, Vingerling JR, de Jong PT, et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 2006, 124:529-535.
21. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991, 98:1128-1134.
22. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995, 39:367-374.
23. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995, 102:205-210.
24. Lunn D, Spiegelhalter D, Thomas A, Best N The BUGS project: evolution, critique and future directions. Stat Med 2009, 28:3049-3067.
25. Denwood MJ runjags: Interface utilities for MCMC models in Just Another Gibbs Sampler (JAGS) using parallel and distributed computing methods (accessed Dec 30, 2013). http://www2.uaem.mx/r-mirror/web/packages/runjags/index.html.
26. Dellaportas P, Forster JJ, Ntzoufras I On Bayesian model and variable selection using MCMC. Stat Comput 2002, 12:27-36.
27. Jeffreys H Theory of probability 1961, The Clarendon Press, Oxford. 3rd edn.
28. World population prospects: the 2010 revision population database United Nations Population Division, (accessed Nov 26, 2013). http://esa.un.org/wpp/Documentation/WPP%202010%20publications.htm.
29. Das BN, Thompson JR, Patel R, Rosenthal AR The prevalence of eye disease in Leicester: a comparison of adults of Asian and European descent. J R Soc Med 1994, 87:219-222.
30. Liu Y, Wen F, Huang S, et al. Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol 2007, 245:1441-1445.
31. Lee GKY, Wong AL, Luk FOJ, Lai TYY Visual outcome of retinal angiomatous proliferation in Chinese patients following photodynamic therapy or direct laser photocoagulation. Hong Kong J Ophthalmol 2009, 13:5-8.
32. Maruko I, Iida T, Saito M, Nagayama D, Saito K Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007, 144:15-22.
33. Yang K, Liang YB, Gao LQ, et al. Prevalence of age-related macular degeneration in a rural Chinese population: the Handan Eye Study. Ophthalmology 2011, 118:1395-1401.
34. Nangia V, Jonas JB, Kulkarni M, Matin A Prevalence of age-related macular degeneration in rural central India: the Central India Eye and Medical Study. Retina 2011, 31:1179-1185.
35. Cheung CM, Tai ES, Kawasaki R, et al. Prevalence of and risk factors for age-related macular degeneration in a multiethnic Asian cohort. Arch Ophthalmol 2012, 130:480-486.
36. Jenchitr W, Ruamviboonsuk P, Sanmee A, Pokawattana N Prevalence of age-related macular degeneration in Thailand. Ophthalmic Epidemiol 2011, 18:48-52.
37. Vinding T Age-related macular degeneration. An epidemiological study of 1000 elderly individuals. With reference to prevalence, funduscopic findings, visual impairment and risk factors. Acta Ophthalmol Scand 1995, 217(Suppl):1-32.
38. Rouhiainen H, Terasvirta M Kuopio eye survey (KEYS). Acta Ophthalmol (Copenh) 1990, 68:554-558.
39. Klein BE, Klein R Cataracts and macular degeneration in older Americans. Arch Ophthalmol 1982, 100:571-573.
40. Gibson JM, Rosenthal AR, Lavery J A study of the prevalence of eye disease in the elderly in an English community. Trans Ophthalmol Soc UK 1985, 104(Pt 2):196-203.
41. Kini MM, Leibowitz HM, Colton T, et al. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study. Am J Ophthalmol 1978, 85:28-34.
42. Haddad S, Chen CA, Santangelo SL, Seddon JM The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol 2006, 51:316-363.
43. Swaroop A, Chew EY, Rickman CB, Abecasis GR Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 2009, 10:19-43.
44. Priya RR, Chew EY, Swaroop A Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management. Ophthalmology 2012, 119:2526-2536.
45. Chakravarthy U, Wong TY, Fletcher A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 2010, 10:31.
46. Evans JR Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001, 20:227-253.
47. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001, 108:697-704.
48. Oshima Y, Ishibashi T, Murata T, et al. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol 2001, 85:1153-1157.
49. Kawasaki R, Wang JJ, Aung T, et al. Prevalence of age-related macular degeneration in a Malay population: the Singapore Malay Eye Study. Ophthalmology 2008, 115:1735-1741.
50. Chen SJ, Cheng CY, Peng KL, et al. Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Invest Ophthalmol Vis Sci 2008, 49:3126-3133.
51. Klein R, Meuer S, Myers C, et al. Harmonizing the classification of age-related macular degeneration in the three continent AMD consortium. Ophthalmic Epidemiol (in press).